A way of expressing a difference in standard deviations rather than in seconds or centimetres, so results from unlike tests can be pooled. Roughly, 0.2 counts as small and 0.5 as moderate.
Caffeine has a substantial evidence base in sport but its applicability to female team sport athletes is insufficiently defined, and the authors cite an audit in which women were 23 percent of participants across 1826 supplement studies.
Earlier female focused reviews were limited by few female only trials and by two level models that treat multiple correlated effects from the same participants as independent, which overstates precision.
Drawn from the paper's introduction, which states an aim rather than a hypothesis.
The reviewers looked for randomised, placebo controlled crossover trials of a defined caffeine dose in female team sport athletes, and found 26. Basketball, volleyball, handball, soccer, softball, rugby and water polo were all represented, mostly at elite or well trained level. Doses ran from 1.92 to 9 mg per kg, usually as capsules, taken a median of 60 minutes before testing. Because each trial contributes several results at once, the analysis used a three level model that keeps effects from the same study grouped rather than treating them as independent.
Physical performance came out at a Hedges g of 0.32, with a confidence interval of 0.22 to 0.42. Inside that, repeated sprint ability scored 0.43, agility and change of direction 0.42, sprint speed 0.39, anaerobic power 0.30 and jumping 0.29. Perceptual responses improved by 0.42, driven mainly by lower ratings of perceived exertion at 0.35. Sport specific skills pooled at 0.36, but the interval ran from minus 0.01 to 0.73, so it did not clear the line. Heart rate rose on caffeine, which is what a stimulant does.
Two things temper this. Not one of the 26 trials reached low risk of bias, mostly for thin reporting of randomisation and of how results were selected, and three were rated high risk because caffeine is hard to hide from the person taking it. That matters most for perceived exertion and for all out efforts, where belief can move the number. The cognitive estimate rests on four studies, which the authors rate as very low certainty and ask readers not to treat as a benefit.
| undefined | undefined |
| undefined | undefined |
| undefined | undefined |
| undefined | undefined |
Proposed by the authors This is the explanation the authors offer in their discussion. This study did not test it.
The authors explain the physical results by caffeine acting as a non selective adenosine receptor antagonist that relieves central inhibition, increases motor cortex excitability and motor unit recruitment, and may improve calcium handling.
For the perceptual result they argue the same adenosine antagonism attenuates central fatigue signalling and the perception of effort, so a workload that feels easier can be sustained longer as fatigue accumulates.
They point to their own pooled data as consistent with that reading, since perceived exertion fell while heart rate rose slightly, though the receptor level steps were not measured.
Drawn from the discussion sections on physical performance and on perceptual responses.
It is now more likely that acute caffeine gives female team sport athletes a small, outcome specific benefit concentrated in explosive and repeated high intensity efforts and in lower perceived exertion, and not a general benefit for technical skills or cognition. It also contradicts any expectation of a tidy dose response.
Young adult and adult female team sport athletes, mostly elite or well trained, given a single acute dose and assessed largely in laboratory style tests rather than competitive match play. The authors say the findings should not be extended to adolescent athletes.
Adequately powered female specific trials that prospectively verify menstrual cycle phase, hormonal contraceptive use and habitual intake, prespecify sport specific skills and cognition as primary outcomes, and power genotype as an effect modifier rather than adding it afterwards.
Newsletter
Each issue by email, when the newsletter launches. Leaving your address puts you on the list, nothing is sent yet.